“It was pretty evident right away that it was in pulse with my heart,” Jilbert said. Jilbert suffers from pulsatile tinnitus, a condition that makes people able to hear their heartbeat. “If you hear a ...

Patients with pulsatile tinnitus are beset by a sound that surges with every beat of their heart. For those who seek medical ...

Serenity Medical, a NeuroTechnology Investors (NTI) portfolio company and pioneer in venous sinus stenosis treatment, today announced the Company received U.S. Food and Drug Administration (FDA) ...

Pharma - The expanding field of peptide-based inquiry has increasingly gravitated toward compounds that interact with ...

GE HealthCare today announced Allia™ platform upgrade pathways designed to help customers modernize select legacy Innova™ and Discovery™ Image Guiding Solutions (IGS) systems. These pathways provide ...

Dysregulation of bile acid homoeostasis is a central pathogenic mechanism underlying several liver diseases. A promising therapeutic target for such diseases is the farnesoid X receptor (FXR), a ...

Researchers developed linafexor, a short-acting FXR agonist that mimics bile acid rhythms. In clinical trials, the drug improved disease-related markers and showed safety advantages, supporting ...

Detailed price information for Cingulate Inc WT (CINGW-Q) from The Globe and Mail including charting and trades.

Global pivotal Phase 3 trial will evaluate efficacy and safety of atebimetinib + modified gemcitabine/nab-paclitaxel (mGnP) compared to standard ...

Researchers at the Ohio University Heritage College of Osteopathic Medicine have discovered new information about how type 2 diabetes develops and how future treatments may help protect ...

NEWTON, Mass.--(BUSINESS WIRE)--Draig Therapeutics, a clinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies, presented today an oral presentation ...